Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts on Monday, August 27, 2018 at 9:00 a.m. EDT. The purpose of the call is to review the Tafamidis data presentation at the ESC Congress 2018 organized by the European Society of Cardiology.
To view and listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com/investorsbeginning today. Participants are advised to pre-register in advance of the conference call.
You can also listen to the conference call by dialing either (855) 895-8759 in the United States and Canada or (503) 343-6044 outside of the United States and Canada. The password is “ESC”.
Visitors to www.pfizer.com/investors will be able to view and listen to an archived copy of the webcast of the conference call.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.